Registration - In-house Corporation

BioVectra Inc. / valana Deighan, General Counsel

Registration Information

In-house Corporation name: BioVectra Inc.
Responsible Officer Name: valana Deighan, General Counsel
Responsible Officer Change History
Initial registration start date: 2017-10-09
Registration status: Active
Registration Number: 960452-361154

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 11 of 15 (2023-01-30 to 2023-12-31)

Registration versions:

Version 11 of 15 (2023-01-30 to 2023-12-31)

Lobbying Information

Subject Matters

Economic Development

Subject Matter Details

Grant, Contribution or Other Financial Benefit

BioVectra received funding to allow the corporation to expand API and scaled biologics capacity in the Atlantic Canada region from Canada’s Strategic Innovation Fund (SIF) in the amount of $21.1M, all of which was collected during 2021 fiscal year. Subsequent to 2021, BioVectra applied and received approval in for funding to expand existing technologies in biomanufacturing and mRNA vaccine production totaling $39.8M from the Strategic Innovation Fund (SIF). Both SIF funding agreements are in the form of grants and repayable loan. BioVectra also sought funding from provincial governments in both Nova Scotia and PEI to support capital investment, labor cost and other operational costs associated with the biomanufacturing and mRNA production. Those funding agreements came in the form of non-repayable grant, tax incentives and repayable contribution. BioVectra was awarded and collected funding in full in the amount of $1.87M from NRC-IRAP to develop a concept for the manufacturing of COVID-19 vaccines

Communication Techniques

Written communication
Oral communication

Government Institutions

Atlantic Canada Opportunities Agency (ACOA)
Canada Revenue Agency (CRA)
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)

In-house Corporation Details

Description of activities

BioVectra is a contract development and manufacturing organization (CDMO) that serves pharmaceutical and biotech companies with full-service Current Good Manufacturing Practice (cGMP) outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs).

Responsible officer name and position during the period of this registration

Oliver Technow, Chief Executive Officer

Government funding

End date of the last completed financial year: 2022-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Atlantic Canada Opportunities Agency (ACOA)	$432,734.47	No
Innovation PEI	$79,028.85	Yes
Labor Market Development Program -Skills PEI	$34,863.61	Yes
PEI Labour Rebate	$641,198.75	Yes
Réseau de développement économique et d’employabilité (RDEE) PEI - Wage Rebate	$493.50	Yes

In-house Corporation Contact Information

Address:
11 Aviation Avenue
Charlottetown, PE C1E 0A1
Canada

Telephone number: 902-566-9116
Fax number: 902-628-2045

Parent Company Information

102374 PEI Inc.
- 97 Queen Street, Suite 600,
  Charlottetown, PE C1A 4A9
  Canada

Subsidiary Beneficiary Information

BioVectra Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Valana Deighan, General Counsel | No public offices held
Heather Delage, Chief Commercial Officer | No public offices held
Scott Doncaster, VP, Manufacturing Technologies & Engineering | No public offices held
David Long, Chief Financial Officer | No public offices held
Marc Sauer, Chief Science Officer | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Oliver Technow, Chief Executive Officer | No public offices held

BioVectra Inc.

The following names have been used on or after July 2, 2008

Name	From	To
BioVectra Inc.	2017-10-09	current

BioVectra Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
valana Deighan	2025-01-01	Current
Oliver Technow	2017-10-09	2025-01-01

Date Modified:: 2025-04-30

Search and menus

Language selection

Registration - In-house Corporation

BioVectra Inc. / valana Deighan, General Counsel

Registration Information

Associated Communications

Version 11 of 15 (2023-01-30 to 2023-12-31)

Version 11 of 15 (2023-01-30 to 2023-12-31)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties